Black Rose Industries Ltd. announced its financial results for the fiscal year 2025-26, reporting a 7.34% year-on-year increase in Profit After Tax (PAT) to ₹224.96 million. The company's revenue from operations for the year stood at ₹3258.38 million. EBITDA for the period grew by 8.27% to ₹354.33 million, driven by operational efficiencies and a favourable product mix.

Financial Performance

The company's standalone financials for the full year show a decline in revenue from operations by 4.36% to ₹3258.38 million from ₹3406.85 million in the previous year. However, profitability metrics improved significantly. EBITDA margins expanded to 11.0% in FY26 from 9.7% in FY25. PAT margins also improved to 7.0% from 6.3% in the corresponding period of the previous year.

Segmental Performance

The business presence is divided into chemical distribution and chemical manufacturing. The manufacturing segment demonstrated strong growth, with revenue increasing to ₹1141 million in FY26 from ₹948 million in FY25. EBITDA for this segment rose to ₹251 million from ₹172 million. The distribution segment reported revenue of ₹2091 million, a decrease from ₹2431 million in the previous year, with EBITDA at ₹173 million compared to ₹210 million.

Balance Sheet and Ratios

The company's net worth increased to ₹1692.8 million in FY26 from ₹1526.5 million in FY25. Total debt reduced significantly, bringing the debt-to-equity ratio down to 0.01 from 0.06 in the previous year. Return on Capital Employed (ROCE) improved to 18.24% from 17.89%, while Return on Equity (ROE) stood at 13.29% compared to 13.90% in FY25.

Business Outlook

For the current quarter, the company expects domestic demand for acrylamide liquid to pick up in the second half. The outlook for chemical distribution focuses on new product additions and expanding the end-user customer base. The company is also advancing its PAM solid project to the piloting stage and developing new downstream acrylamide products to diversify its portfolio.

Black Rose Industries held its Board of Directors meeting on May 13, 2026, and approved the standalone and consolidated audited financial results for the quarter and year ended March 31, 2026. Subsequently, pursuant to Regulation 47 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, the company published an extract of its audited financial results (standalone and consolidated) in Business Standard (English Edition) and Mumbai Lakshadeep (Marathi Edition) on May 15, 2026. The statutory auditors, M/s. M M Nissim & Co LLP, Chartered Accountants (Firm Regn. No. 107122W/W100672), issued an unmodified audit opinion on the financial results.

Standalone Financial Performance

The company's standalone financials for the year ended March 31, 2026, reflect a moderation in revenue alongside a decline in net profit compared to the prior year. The following table presents the key standalone financial metrics:

On a standalone basis, paid-up equity share capital stood at ₹510.00 lakhs (face value ₹1 per share), while other equity excluding revaluation reserve was ₹16,418.02 lakhs as at March 31, 2026, compared to ₹14,754.88 lakhs as at March 31, 2025. During the quarter, the company recognised an additional ₹33.43 lakhs in the defined benefit obligation for gratuity towards past service cost, charged under employee benefit expenses in accordance with India's new Labour Codes and Ind AS 19.

Standalone Balance Sheet Highlights

The standalone statement of assets and liabilities as at March 31, 2026, reflects the following position (₹ in Lakhs):

Standalone Cash Flow Summary

The standalone cash flow statement for the year ended March 31, 2026, showed a significant improvement in operating cash generation (₹ in Lakhs):

Consolidated Financial Performance

The consolidated results include the financial results of wholly owned subsidiary B.R. Chemicals Co. Limited, whose business operations have been classified as discontinued operations in accordance with Ind AS 105, following the Board's decision to initiate steps for the closure, sale, or transfer of 100% of its shareholding in the subsidiary. The key consolidated financial metrics are presented below:

The discontinued subsidiary reported total income of ₹1.39 lakhs, expenses of ₹8.58 lakhs, a loss of ₹7.19 lakhs, and a comprehensive loss of ₹5.50 lakhs for the year ended March 31, 2026. Consolidated other equity excluding revaluation reserve stood at ₹16,433.61 lakhs as at March 31, 2026, compared to ₹14,775.97 lakhs as at March 31, 2025.

Consolidated Balance Sheet Highlights

The consolidated statement of assets and liabilities as at March 31, 2026, is summarised below (₹ in Lakhs):

Dividend Recommendation

The Board of Directors recommended a final dividend of ₹1.25 per equity share (i.e., at 125% on the paid-up share capital) for the financial year ended March 31, 2026. The payment is subject to approval of shareholders at the ensuing Annual General Meeting.

Key Corporate Appointments

The board approved several significant personnel and governance changes at the May 13, 2026 meeting. The details are summarised below:

Mr. Ambarish Daga is a financial analyst with a background in operations management who manages overall corporate activities, and is not related to any director of the company. Mrs. Shruti Jatia has a career spanning over three decades in finance, accounts, and business operations, and is related to Mr. Anup Jatia, Non-Executive Director and Chairman of the company. Ms. Darshana Sawant (M. No.: A63226) is an Associate Member of the Institute of Company Secretaries of India with experience in compliance under the Companies Act, 2013, Listing Regulations, and other corporate laws.

Regulatory Disclosure and Company Background

In line with the company's Internal Code for Prevention of Insider Trading, the trading window for dealing in the company's securities had been closed from April 1, 2026, and will remain closed until 48 hours after the announcement of the financial results. The full format of the standalone and consolidated financial results is available on the BSE website at www.bseindia.com and on the company's website at www.blackrosechemicals.com . Black Rose Industries is headquartered at 145/A, Mittal Towers, Nariman Point, Mumbai – 400 021, with its factory located at Shree Laxmi Co-op. Industrial Estate Ltd., Hatkanangle, Dist. Kolhapur, Maharashtra. The company's CIN is L17120MH1990PLC054828, and its business activity falls within a single primary business segment of "Chemicals", with no separate reportable segments as per Ind AS 108.